Tuberculosis behind bars or the disease is not a sentence. Clinical experience of using the drug Perchlozon® in patients with tuberculosis with multy- and extended drug resistance in the moscow penitenciary

This article contains the main statistical indicators of tuberculosis among arrested and convicted persons, holding in institutions of the penitentiary system of Moscow and Russia over the period from 2016 to 2019. On the territory of Moscow all medical measures among these persons with tuberculosis are provided in conditions of the tuberculosis pulmonary departments № 1, 2 of the Hospital of the Federal state healthcare institution Medical and sanitary part-77 of the Federal Penitentiary Service of Russia. The work describes its structure and tasks. Taking into account the specifics of the group of patients, the article focuses on persons with tuberculosis/HIV co-infection. The main orders of the Federal Penitentiary Service, regulating the treatment of patients in places of deprivation of liberty, are also highlighted. The hospital uses an individual approach to each patient, including patients with tuberculosis in combination with multiple and broad drug resistance. The article considers two clinical cases, reflects the main points of clinical and diagnostic dynamics in the treatment of patients with pulmonary tuberculosis with the drug Perchlozon®. Because of the analysis of these clinical examples it follows, that on the background of the use of the drug «Perchlozon» in the scheme of the IV chemotherapy regimen, after 6 months from starting of treatment, there is abacillation and scarring of the decay cavities at the patients. It plays an important role in returning a sick person to a healthy employable society, as well as in normalization of his psychoemotional state.